Nanogen Inc and Transgenomic Inc. today announced that they have entered into an agreement allowing Transgenomic to distribute Nanogen's NanoChip Molecular Biology Workstation in selected Western European countries. Transgenomic's European marketing and sales organization will market, sell and service the instrument. The NanoChip Workstation is an automated, open-architecture instrument that facilitates routine detection of known genetic variation, complementing the Transgenomic WAVE System's ability to scan for unknown genetic variation.
The quest by researchers to associate genetic variation with clinical observations and outcomes potentially requires multiple technologies, depending on the specific situation. Transgenomic's WAVE System offers an accurate and cost-effective solution when it is necessary to scan for all possible genetic variation, known or unknown. In addition, WAVE technology has proven highly effective in detecting low-abundance genetic variation, such as somatic mutations that may arise during the course of cancer progression or in the development of drug resistance. Nanogen's NanoChip Molecular Biology Workstation is an extremely flexible platform that facilitates routine detection of known genetic sequences, such as detection of SNPs and short tandem repeats (STRs) using the NanoChip Electronic Microarray. The unique, open-architecture design permits researchers to define, select and build their own test panels, or select from Nanogen-developed analyte specific reagents designed to detect mutations associated with various diseases.
Posted 15th January 2004
Please use one of the following formats to cite this article in your essay, paper or report:
Nanogen. (2023, February 14). Nanogen and Transgenomic Enter into Distribution Agreement. AZoNano. Retrieved on June 01, 2023 from https://www.azonano.com/article.aspx?ArticleID=427.
Nanogen. "Nanogen and Transgenomic Enter into Distribution Agreement". AZoNano. 01 June 2023. <https://www.azonano.com/article.aspx?ArticleID=427>.
Nanogen. "Nanogen and Transgenomic Enter into Distribution Agreement". AZoNano. https://www.azonano.com/article.aspx?ArticleID=427. (accessed June 01, 2023).
Nanogen. 2023. Nanogen and Transgenomic Enter into Distribution Agreement. AZoNano, viewed 01 June 2023, https://www.azonano.com/article.aspx?ArticleID=427.
Do you have a review, update or anything you would like to add to this article?
Cancel reply to comment
Dr. Jeffrey Dick
In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Jeffrey Dick about his work studying the chemistry of small volumes and nano-electrochemical tools.
Here, AZoNano speaks with Dirigent Acoustics about the benefits graphene could bring to acoustic and audio technologies and how the company's relationship with the Graphene Flagship has shaped its success.
In this interview, KLA's Bryan Crawford explains everything there is to know about nanoindentation, the challenges that the field currently faces, and how they can be overcome.
The Diamond Interaction Chamber (DIXC) is integral to the NanoGenizer high-pressure homogenizer.
The new AUTOsample-100 mounting autosampler is compatible with the 100 MHz benchtop NMR spectrometer.
The Vistec SB3050-2 is the most advanced electron beam lithography system with variable-shaped beam technology, allowing a wide range of applications in research and development, prototyping, and small-volume production.